COVID-19 Related Health and Infection Control Practices Among Dentists
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04423770 |
Recruitment Status :
Completed
First Posted : June 9, 2020
Last Update Posted : July 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Severe Acute Respiratory Syndrome Coronavirus 2 | Other: No intervention |
Study Type : | Observational |
Actual Enrollment : | 2196 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Prospective |
Official Title: | COVID-19 Related Health and Infection Control Practices Among Dentists |
Actual Study Start Date : | June 8, 2020 |
Actual Primary Completion Date : | June 8, 2021 |
Actual Study Completion Date : | June 8, 2021 |

Group/Cohort | Intervention/treatment |
---|---|
U.S. dentists
Dentists in the United States
|
Other: No intervention
No intervention; this is a purely observational study |
- COVID-19 probable or confirmed case [ Time Frame: 18 months ]COVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen
- Anxiety [ Time Frame: 12 months ]Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.
- Depression [ Time Frame: 12 months ]Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.
- Dental practice infection control efforts [ Time Frame: 12 months ]Self-reports of infection control efforts in the respondents' primary dental practices
- Dentists' use of personal protective equipment [ Time Frame: 12 months ]Self-reports of personal protective equipment use

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Primary dental practice is in United States
- 18 years of age or older
- Dentist
Exclusion Criteria:
•Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04423770
United States, Illinois | |
American Dental Association | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Cameron G Estrich, MPH, PhD | American Dental Association Science and Research Institute |
Responsible Party: | Cameron Estrich, Health Research Analyst, American Dental Association |
ClinicalTrials.gov Identifier: | NCT04423770 |
Other Study ID Numbers: |
20-08 |
First Posted: | June 9, 2020 Key Record Dates |
Last Update Posted: | July 22, 2021 |
Last Verified: | July 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
SARS-CoV-2 COVID-19 survey dentistry infection control |
Infections COVID-19 Severe Acute Respiratory Syndrome Respiratory Tract Infections Pneumonia, Viral Pneumonia Virus Diseases |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases |